Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: PETS

PetMed Express, Inc.

Healthcare | Medical - Pharmaceuticals

No licensed closing price on file for PETS. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

EPS (TTM)$-1.37

PetMed Express, Inc. (NASDAQ: PETS) is a pharmaceutical company. Figures from SEC EDGAR; updated 2026-10-20 09:03 UTC.

What PetMed Express, Inc. does

PetMeds Express, operating the brands PetMeds and PetCareRx, is a direct-to-consumer pet health and wellness retailer that sells prescription medications, over-the-counter products, compounded medications, and pet food through websites, mobile applications, and customer contact centers. The company connects customers' orders to their licensed veterinarians for prescription approval and offers educational content through a separate website. PetMeds acquired PetCareRx in April 2023, expanding its product catalog to include non-prescription food and supplies.

Summarized from PetMed Express, Inc.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Pre-revenue, development-stage company: standard profitability ratios (P/E, EV/EBITDA, ROE) do not apply yet because there are no earnings. Watch cash, cash runway, net loss, R&D spend and share dilution instead.

Key facts

Valuation
EPS (TTM)$-1.37

Revenue, margins & earnings

FY2022 Net income: $19MFY2022 Taxes & interest: $6MFY2022 Operating expenses: $53MFY2022 Cost of revenue: $195M$272MFY2022FY2023 Net income: $5MFY2023 Operating expenses: $70MFY2023 Cost of revenue: $171M$248MFY2023FY2024: net loss $7M on revenue $274M$274MFY2024FY2025: net loss $6M on revenue $227M$227MFY2025FY2026: net loss $57M on revenue $179M$179MFY2026
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
  • Net loss year
Annual revenue; bands show net, operating, gross margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-09-29
  • 2026-09-29CEO and PresidentPerformance Share UnitsAward250,000—
  • 2026-09-29CEO and PresidentAward250,000—
  • 2026-09-21DirectorAward49,923—
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does PetMed Express, Inc. do?

PetMeds Express, operating the brands PetMeds and PetCareRx, is a direct-to-consumer pet health and wellness retailer that sells prescription medications, over-the-counter products, compounded medications, and pet food through websites, mobile applications, and customer contact centers.

When did PETS last file with the SEC?

PetMed Express, Inc.'s most recent SEC filing on record is a 8-K filed 2026-06-26. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-20 09:03 UTC. This page is also available as JSON at /api/data?ticker=PETS and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for PETS and 5,000+ tickers.

Create a free account — keep PETS
For your agent
GET /api/data?ticker=PETS

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt